| Name | N,N'-bis-(3-dimethylamino-propyl)-3,9-dimethylquinolino[8,7-h]quinolin-1,7-diamine | CAS# | 501081-38-5 | |
|---|---|---|---|---|
| Price | $Inquiry/100mg $Inquiry/250mg $Inquiry/1g | Purity | 98.0% | |
| Stocking Period |
3 Day | Stock | In Stock | |
| Product Webpage: | http://www.dcchemicals.com/product_show-DC21014.html | |||
| Detail
Product Information
FGI-106 is a broad-spectrum inhibitor of multiple blood-borne viruses (HCV, HBV, HIV) as well as emerging biothreats (Ebola, VEE, Cowpox, PRRSV infection) with EC50 of 0.2-10 uM; inhibits the interaction of TSG101 with its cognate viral ligands; displays an ability to prevent lethality from Ebola in vivo; well-tolerated and orally bioavailable. |